Advancing Cancer Treatment: Ivonescimab’s Poten...

By Rene Pretorius

February 28, 2025

Ivonescimab, a novel bispecific antibody targeting PD-1 and VEGF, is showing significant promise in treating non-small cell lung cancer (NSCLC) and other solid tumors. Recent ivonescimab clinical trials have demonstrated its ability to enhance pro...
ACS Management Innovations: Transforming Patient Outcomes in Acute Coronary S...
New Global AIDS Strategy 2030 Aims to End AIDS Threat by 2030
Hypertension Detection: HTN-AI Model for Cardiovascular Risk Stratification
CVD Prevention Models in Sub-Saharan Africa: Insights and Gaps
Strengthening Africa Health Partnership
Urgent Call for Enhanced Breast Cancer Africa Control Measures
Journavx Pain Management: FDA Approves New Non-Opioid Treatment for Acute Pain
Engineered Heart Muscle Allografts Show Promise in Heart Repair
HPV Vaccination Males: Addressing High Infection Rates and Preventing Cervica...
Healthcare at Home: CMC Dubai’s Innovative Program
The Urgent Need for Cancer Screening in South Africa
Improving Cervical Cancer Diagnosis with Nanotechnology in Menstrual Products